» Articles » PMID: 30962627

Bromodomain Inhibition of the Coactivators CBP/EP300 Facilitate Cellular Reprogramming

Overview
Journal Nat Chem Biol
Date 2019 Apr 10
PMID 30962627
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Silencing of the somatic cell type-specific genes is a critical yet poorly understood step in reprogramming. To uncover pathways that maintain cell identity, we performed a reprogramming screen using inhibitors of chromatin factors. Here, we identify acetyl-lysine competitive inhibitors targeting the bromodomains of coactivators CREB (cyclic-AMP response element binding protein) binding protein (CBP) and E1A binding protein of 300 kDa (EP300) as potent enhancers of reprogramming. These inhibitors accelerate reprogramming, are critical during its early stages and, when combined with DOT1L inhibition, enable efficient derivation of human induced pluripotent stem cells (iPSCs) with OCT4 and SOX2. In contrast, catalytic inhibition of CBP/EP300 prevents iPSC formation, suggesting distinct functions for different coactivator domains in reprogramming. CBP/EP300 bromodomain inhibition decreases somatic-specific gene expression, histone H3 lysine 27 acetylation (H3K27Ac) and chromatin accessibility at target promoters and enhancers. The master mesenchymal transcription factor PRRX1 is one such functionally important target of CBP/EP300 bromodomain inhibition. Collectively, these results show that CBP/EP300 bromodomains sustain cell-type-specific gene expression and maintain cell identity.

Citing Articles

Generation of Bona Fide Human Induced Trophoblast Stem Cells by Direct Reprogramming of Term Umbilical Cord Cells.

van Voorden A, Boussata S, Keijser R, Vermij M, Wagner M, Ganzevoort W Int J Mol Sci. 2025; 26(1.

PMID: 39796127 PMC: 11719488. DOI: 10.3390/ijms26010271.


Epigenetic drug screening identifies enzyme inhibitors A-196 and TMP-269 as novel regulators of sprouting angiogenesis.

Beter M, Pulkkinen H, Ord T, Sormunen A, Kilpelainen L, Dunford J Sci Rep. 2025; 15(1):1628.

PMID: 39794417 PMC: 11724134. DOI: 10.1038/s41598-024-84603-w.


A rapid chemical reprogramming system to generate human pluripotent stem cells.

Wang Y, Peng F, Yang Z, Cheng L, Cao J, Fu X Nat Chem Biol. 2025; .

PMID: 39753706 DOI: 10.1038/s41589-024-01799-8.


Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application.

Chen Y, Liang R, Li Y, Jiang L, Ma D, Luo Q Signal Transduct Target Ther. 2024; 9(1):340.

PMID: 39627201 PMC: 11615378. DOI: 10.1038/s41392-024-02030-9.


Mouse Embryonic Fibroblasts Reprogramming to Induced Pluripotent Stem Cells by T3.

Montero-Pedrazuela A, Contreras-Jurado S Methods Mol Biol. 2024; 2876:117-130.

PMID: 39579312 DOI: 10.1007/978-1-0716-4252-8_8.


References
1.
Yao T, P Oh S, Fuchs M, Zhou N, ChNg L, Newsome D . Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell. 1998; 93(3):361-72. DOI: 10.1016/s0092-8674(00)81165-4. View

2.
Merika M, Williams A, Chen G, Collins T, Thanos D . Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell. 1998; 1(2):277-87. DOI: 10.1016/s1097-2765(00)80028-3. View

3.
Onder T, Kara N, Cherry A, Sinha A, Zhu N, Bernt K . Chromatin-modifying enzymes as modulators of reprogramming. Nature. 2012; 483(7391):598-602. PMC: 3501145. DOI: 10.1038/nature10953. View

4.
Sims D, Ilott N, Sansom S, Sudbery I, Johnson J, Fawcett K . CGAT: computational genomics analysis toolkit. Bioinformatics. 2014; 30(9):1290-1. PMC: 3998125. DOI: 10.1093/bioinformatics/btt756. View

5.
Simandi Z, Horvath A, Wright L, Cuaranta-Monroy I, De Luca I, Karolyi K . OCT4 Acts as an Integrator of Pluripotency and Signal-Induced Differentiation. Mol Cell. 2016; 63(4):647-661. DOI: 10.1016/j.molcel.2016.06.039. View